ABROCITINIB Pharmacologic Class Indexing
- Class set ID
- d09ee6e6-a625-4e4e-ac31-da0d6ef9ae87
- Version
- 1
- Effective date
- 20220224
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use CIBINQO safely and effectively. See full prescribing information for CIBINQO. CIBINQO ® (abrocitinib) tablets, for oral use Initial U.S. Approval: 2022 | U.S. Pharmaceuticals | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH | Packaging Coordinators, LLC | 20250320 | 4 |
| These highlights do not include all the information needed to use CIBINQO safely and effectively. See full prescribing information for CIBINQO. CIBINQO ® (abrocitinib) tablets, for oral use Initial U.S. Approval: 2022 | Pfizer Laboratories Div Pfizer Inc | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Deutschland GmbH | 20250109 | 6 |